| It is currently Sat May 25, 2013 9:50 am |
|
All times are UTC - 8 hours [ DST ] |
|
Page 1 of 1 |
[ 3 posts ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1689 |
|
|||||
| Top | |
|||||
| Daisy3 |
|
|||||
Joined: Tue Feb 09, 2010 4:00 pm Posts: 302 |
|
|||||
| Top | |
|||||
| euphoniaa |
|
|||||
Joined: Sat Jul 15, 2006 3:00 pm Posts: 607 Location: midwest U.S. |
|
|||||
| Top | |
|||||
|
Page 1 of 1 |
[ 3 posts ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
| The FDA grants Priority Review status to Anegren | 3 | 1339 | Mon Jun 28, 2004 11:56 am | ||
| US priority review status for oral MS drug Cladribine | 0 | 666 | Wed Jul 28, 2010 12:41 am | ||
| FDA extends priority review of oral MS drug Cladribine | 0 | 868 | Fri Nov 26, 2010 3:44 am | ||
| FDA review of oral MS drug FTY720 extended | 1 | 830 | Tue May 25, 2010 5:15 pm | ||
| Novartis shares genome info | 0 | 733 | Tue Feb 13, 2007 9:35 pm | ||
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |